ArticleEnvironmental monitoring and assessment2026
Persistence of environmental and wastewater-associated antibiotic resistance in river water.
Article in Environmental monitoring and assessment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
River water serves both as a recipient of anthropogenic antibiotic resistance (AR) via wastewater and as a reservoir of AR that can disseminate and pose risks to human and animal health. However, the fate of AR from anthropogenic and environmental sources in aquatic ecosystems remains poorly understood. In this microcosm study, we investigated the persistence of AR vectors over 10 weeks using river water from two European sites, with and without the addition of 5% (v/v) wastewater. We employed a combination of culture-based techniques, quantitative PCR, 16S rRNA gene sequencing, and genome sequencing of isolates to track both anthropogenic and environmental AR components. Our findings demonstrated the rapid decline of AR vectors associated with anthropogenic sources such as extended-spectrum beta-lactamase (ESBL)-producing E. coli, bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.